Translational Center for Metabolic Imaging Department of Radiology, University of Washington, Seattle, WA.
Department of Medicine, University of Washington, Seattle, WA.
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):826-833. doi: 10.1002/jcsm.12318. Epub 2018 Sep 26.
Building both strength and endurance has been a challenge in exercise training in the elderly, but dietary supplements hold promise as agents for improving muscle adaptation. Here, we test a formulation of natural products (AX: astaxanthin, 12 mg and tocotrienol, 10 mg and zinc, 6 mg) with both anti-inflammatory and antioxidant properties in combination with exercise. We conducted a randomized, double-blind, placebo-controlled study of elderly subjects (65-82 years) on a daily oral dose with interval walking exercise on an incline treadmill.
Forty-two subjects were fed AX or placebo for 4 months and trained 3 months (3×/week for 40-60 min) with increasing intervals of incline walking. Strength was measured as maximal voluntary force (MVC) in ankle dorsiflexion exercise, and tibialis anterior muscle size (cross-sectional area, CSA) was determined from magnetic resonance imaging.
Greater endurance (exercise time in incline walking, >50%) and distance in 6 min walk (>8%) accompanied training in both treatments. Increases in MVC by 14.4% (±6.2%, mean ± SEM, P < 0.02, paired t-test), CSA by 2.7% (±1.0%, P < 0.01), and specific force by 11.6% (MVC/CSA, ±6.0%, P = 0.05) were found with AX treatment, but no change was evident in these properties with placebo treatment (MVC, 2.9% ± 5.6%; CSA, 0.6% ± 1.2%; MVC/CSA, 2.4 ± 5.7%; P > 0.6 for all).
The AX formulation improved muscle strength and CSA in healthy elderly in addition to the elevation in endurance and walking distance found with exercise training alone. Thus, the AX formulation in combination with a functional training programme uniquely improved muscle strength, endurance, and mobility in the elderly.
在老年人的运动训练中,同时增强力量和耐力一直是一个挑战,但膳食补充剂有望成为改善肌肉适应性的手段。在这里,我们测试了一种具有抗炎和抗氧化特性的天然产品配方(AX:虾青素 12mg,生育三烯酚 10mg 和锌 6mg),并将其与运动相结合。我们对 42 名 65-82 岁的老年人进行了一项随机、双盲、安慰剂对照研究,这些老年人每天口服剂量,并在倾斜跑步机上进行间隔步行运动。
42 名受试者服用 AX 或安慰剂 4 个月,并进行 3 个月的训练(每周 3 次,每次 40-60 分钟),逐渐增加倾斜行走的间隔。通过踝关节背屈运动中的最大自主力(MVC)测量力量,通过磁共振成像确定胫骨前肌的大小(横截面积,CSA)。
在两种治疗中,耐力(倾斜行走的运动时间,>50%)和 6 分钟步行的距离(>8%)都随着训练而增加。AX 治疗组的 MVC 增加了 14.4%(±6.2%,平均值±SEM,P<0.02,配对 t 检验),CSA 增加了 2.7%(±1.0%,P<0.01),比力量增加了 11.6%(MVC/CSA,±6.0%,P=0.05),而安慰剂治疗组这些参数没有明显变化(MVC,2.9%±5.6%;CSA,0.6%±1.2%;MVC/CSA,2.4±5.7%;所有 P>0.6)。
AX 配方除了单独运动训练可以提高耐力和步行距离外,还能提高健康老年人的肌肉力量和 CSA。因此,AX 配方与功能训练方案相结合,可独特地提高老年人的肌肉力量、耐力和活动能力。